These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16454974)

  • 1. Potential role of Chinese medicinal herbs in the prevention of coronary artery restenosis.
    Shen WF
    Chin Med J (Engl); 2006 Jan; 119(1):3-5. PubMed ID: 16454974
    [No Abstract]   [Full Text] [Related]  

  • 2. XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China.
    Chen KJ; Shi DZ; Xu H; Lü SZ; Li TC; Ke YN; Zhang MZ; Lu XY; Sun RY; You SJ
    Chin Med J (Engl); 2006 Jan; 119(1):6-13. PubMed ID: 16454975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restenosis related to percutaneous coronary intervention has been solved?
    Kivelä A; Hartikainen J
    Ann Med; 2006; 38(3):173-87. PubMed ID: 16720432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiology patient page. Drug-eluting stents.
    Maisel WH; Laskey WK
    Circulation; 2007 May; 115(17):e426-7. PubMed ID: 17470700
    [No Abstract]   [Full Text] [Related]  

  • 5. Percutaneous stenting of the left main with drug eluting stents for in-stent restenosis: immediate- and long-term results.
    Mixon T; Fitzsimmons P
    J Invasive Cardiol; 2006 Jun; 18(6):E166-8. PubMed ID: 16775892
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-eluting stents: preventing restenosis.
    Slavin L; Chhabra A; Tobis JM
    Cardiol Rev; 2007; 15(1):1-12. PubMed ID: 17172878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous coronary intervention or coronary artery bypass graft for unprotected left main coronary artery disease: the endless debate.
    Meliga E; Valgimigli M; Buszman P; Serruys PW
    J Am Coll Cardiol; 2008 Aug; 52(7):582-4; author reply 584-6. PubMed ID: 18687257
    [No Abstract]   [Full Text] [Related]  

  • 8. Coronary artery restenosis: a paradigm of current treatment approaches.
    Kiernan TJ; Kiernan GD; Yan BD
    Minerva Cardioangiol; 2009 Feb; 57(1):77-94. PubMed ID: 19202520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and safety of intra-coronary Beta irradiation with 144Ce/Pr for prevention of restenosis after percutaneous transluminal coronary angioplasty of in-stent restenotic lesions.
    Bonvini RF; Hendiri T; Leo G; Aeby N; Noble J; Sigwart U; Verin V
    Acute Card Care; 2006; 8(4):217-23. PubMed ID: 17162548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era?
    Jimenez-Valero S; Moreno R; Sanchez-Recalde A; Galeote G; Calvo L; Viana A; Lopez de Sá E; López-Sendón J
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):137-46. PubMed ID: 19124417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covered stents: a review.
    Jamshidi P; Mahmoody K; Erne P
    Int J Cardiol; 2008 Nov; 130(3):310-8. PubMed ID: 18672301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioabsorbable coronary stents.
    Lobodzinski SS
    Cardiol J; 2008; 15(6):569-71. PubMed ID: 19039765
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of drug-eluting stents: current best available evidence.
    Raja SG; Dreyfus GD
    J Card Surg; 2006; 21(6):605-12; discussion 613-4. PubMed ID: 17073969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying drug-eluting stents in clinical practice.
    King SB
    Am J Cardiol; 2007 Sep; 100(5A):25K-31K. PubMed ID: 17719350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [You prevent more than 80% of restenosis. But are the medication-releasing stents really to be paid for?].
    MMW Fortschr Med; 2004 May; 146(22):49. PubMed ID: 15373114
    [No Abstract]   [Full Text] [Related]  

  • 17. Frugal coronary angioplasty, still an option after 30 years.
    Meier B
    J Invasive Cardiol; 2008 Apr; 20(4):E97-101. PubMed ID: 18398248
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recovery of endothelium, a new policy of integrative Chinese and Western medicine in prevention and treatment of post-PCI restenosis].
    Wang Y; Tang JF; Yang PL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Oct; 24(10):944-6. PubMed ID: 15553834
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
    Newsome LT; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib and hypertension-insights from the effect of celecoxib on restenosis after coronary angioplasty with a taxus stent trial.
    Bangalore S; Khianey S; Messerli FH
    Am J Cardiol; 2008 Apr; 101(7):1068. PubMed ID: 18359335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.